Latest Past Events

Bioblast 2022: Inaugural Conference of Bioenergetics Communications

Congress Innsbruck Rennweg 3, Innsbruck

On June 29-30, Abliva will participate at Bioblast 2022: Inaugural Conference of Bioenergetics Communications in Innsbruck, Austria. Abliva's Communications Officer & Lab Manager, Eleonor Åsander Frostner, will present a summary […]

UMDF’s Mitochondrial Medicine Symposium

JW Marriott Phoenix Desert Ridge Resort & Spa Phoenix

Abliva will participate at the United Mitochondrial Disease Foundation's Mitochondrial Medicine Symposium in Phoenix, Arizona. Abliva's CMO, Magnus Hansson, will participate in a panel discussion on clinical trials together with […]

Mitochondria-Targeted Drug Development Summit

Hyatt Regency Boston/Cambridge 575 Memorial Dr, Cambridge

Abliva will attend and present at the Mitochondria-Targeted Drug Development Summit in Boston, MA, USA. The event will be held on 22 - 24 February 2022. CEO Ellen Donnelly will […]